Please Wait.....
Report
ASEAN Infusion Pump - Company Evaluation Report, 2025
Market Report I 2025-08-01 I 149 Pages I MarketsandMarkets
The ASEAN Infusion Pump Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for ASEAN Infusion Pump. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. MarketsandMarkets 360 Quadrants evaluated over 140 companies, of which the Top 15 ASEAN Infusion Pump Companies were categorized and recognized as quadrant leaders.
The ASEAN infusion pumps market is experiencing significant growth, driven by the rising burden of chronic diseases, expanding healthcare infrastructure, and increasing demand for advanced drug delivery systems. As conditions such as cancer, diabetes, and renal failure become more prevalent across Southeast Asia, hospitals and clinics are increasingly adopting infusion pumps to ensure precise and controlled medication delivery. Countries like Indonesia, Vietnam, Thailand, and the Philippines are rapidly modernizing their healthcare systems, with substantial investments in hospital equipment and critical care technologies further supporting market expansion.
A major growth factor is the region's aging population, which is more susceptible to chronic illnesses requiring long-term intravenous therapies. This demographic shift is fueling consistent demand for infusion pumps in both hospital and homecare settings. In parallel, governments across the ASEAN region are prioritizing healthcare system improvements, leading to increased public and private investments in medical technologies, including infusion systems. Additionally, the availability of cost-effective, locally manufactured infusion devices is making advanced care more affordable and accessible in price-sensitive markets, promoting broader adoption in both urban and rural healthcare facilities.
The 360 Quadrant maps the ASEAN Infusion Pump companies based on criteria such as revenue, geographic presence, growth strategies, investments, and sales strategies for the market presence of the ASEAN Infusion Pump quadrant. The top criteria for product footprint evaluation included By Product (Accessories and Consumables, Devices), By Application (Chemotherapy/Oncology, Diabetes Management, Gastroenterology, Analgesia/Pain Management, Analgesia/Pain Management, Hematology, Other Applications), and By End User (Hospitals, Home Care Settings, Ambulatory Care Settings, Academic & Research Institutes).
Key Players
Key players in the ASEAN Infusion Pump market include major global corporations and specialized innovators such as Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International (US), Fresenius Kabi (Germany), Terumo Corporation (Japan), ICU Medical, Inc. (US), Roche Diagnostics (Switzerland), Nipro (Japan), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Medtronic plc (Ireland), Ypsomed Holding AG (Switzerland), JMS Co., Ltd. (Japan), and Avanos Medical, Inc. (US). These companies are actively investing in research and development, forming strategic partnerships, and engaging in collaborative initiatives to drive innovation, expand their global footprint, and maintain a competitive edge in this rapidly evolving market.
Top 3 Companies
Becton, Dickinson and Company
Becton, Dickinson and Company-commonly known as BD-is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents for healthcare institutions, life science researchers, clinical laboratories, and the pharmaceutical industry. The company operates through three main business segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment, operations are further divided into four business units: Medication Delivery Solutions, Medication Management Solutions, Pharmaceutical Systems, and Diabetes Care.
Fresenius Kabi
Fresenius Kabi, a wholly owned subsidiary of Fresenius SE & Co. KGaA, is a global healthcare company specializing in products and services for dialysis, hospital care, and outpatient medical treatment. The company operates through four primary business segments: Medtech, Nutrition, Biopharmaceuticals, and Pharma Business. Through its Medtech segment, Fresenius Kabi offers a comprehensive range of infusion pumps and related accessories, supporting safe and efficient drug delivery in clinical settings.
Terumo Corporation
Terumo Corporation develops and manufactures a wide range of medical products and equipment, including pharmaceuticals, nutritional supplements, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis solutions, blood glucose monitoring systems, and digital thermometers. The company operates through three main business segments: Cardiac and Vascular, General Hospital Company, and Blood & Cell Technologies.
1 INTRODUCTION 13
1.1 MARKET DEFINITION 13
1.2 INCLUSIONS AND EXCLUSIONS 13
1.3 STAKEHOLDERS 14
2 EXECUTIVE SUMMARY 15
3 MARKET OVERVIEW 19
3.1 MARKET DYNAMICS 19
3.1.1 MARKET DRIVERS 20
3.1.1.1 Rising demand for ambulatory infusion pumps in home care settings 20
3.1.1.2 Rapid growth in geriatric population and subsequent rise in
chronic diseases 20
3.1.1.3 Increased adoption of enteral feeding pumps due to surge in
pre-term births 22
3.1.1.4 Growing number of surgical procedures performed worldwide 23
3.1.1.5 Increased safety & cybersecurity requirements 23
3.1.2 RESTRAINTS 24
3.1.2.1 Product recalls 24
3.1.2.2 Stringent regulatory requirements for new product approvals 24
3.1.2.3 Increasing adoption of refurbished & rented infusion pumps 25
3.1.3 OPPORTUNITIES 25
3.1.3.1 High growth of emerging economies 25
3.1.3.2 Growing popularity of specialty infusion systems 26
3.1.4 CHALLENGES 26
3.1.4.1 Increasing incidence of medication errors and inadequate wireless connectivity in most hospitals 26
3.2 INDUSTRY TRENDS 27
3.2.1 SMART PUMP-EMR INTEROPERABILITY 27
3.2.2 DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 28
3.2.3 GROWING DEMAND FOR SPECIALTY PUMPS WITH ADVANCED FEATURES 30
3.3 TECHNOLOGY ANALYSIS 30
3.3.1 KEY TECHNOLOGIES 30
3.3.1.1 Flow generation 30
3.3.1.2 Smart infusion systems 31
3.3.1.3 Closed-loop infusion control 31
3.3.2 COMPLEMENTARY TECHNOLOGIES 32
3.3.2.1 Dose error reduction systems 32
3.3.2.2 Wireless connectivity 33
3.3.2.3 AI-powered decision support systems 33
3.3.3 ADJACENT TECHNOLOGIES 34
3.3.3.1 Embedded software 34
3.3.3.2 Sensing technology 34
3.4 PORTER'S FIVE FORCES ANALYSIS 35
3.4.1 THREAT OF NEW ENTRANTS 35
3.4.2 THREAT OF SUBSTITUTES 36
3.4.3 BARGAINING POWER OF SUPPLIERS 36
3.4.4 BARGAINING POWER OF BUYERS 36
3.4.5 INTENSITY OF COMPETITIVE RIVALRY 36
3.5 PATENT ANALYSIS 37
3.5.1 PATENT PUBLICATION TRENDS FOR INFUSION PUMPS 37
3.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 38
3.6 KEY CONFERENCES AND EVENTS, 2025-2026 39
3.7 IMPACT OF AI ON ASEAN INFUSION PUMPS MARKET 40
3.7.1 INTRODUCTION 40
3.7.2 MARKET POTENTIAL IN ASEAN INFUSION PUMPS ECOSYSTEM 40
3.7.3 AI USE CASES 41
3.7.4 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 41
3.7.5 FUTURE OF GEN AI IN ASEAN INFUSION PUMPS ECOSYSTEM 42
3.8 ECOSYSTEM ANALYSIS 42
3.9 VALUE CHAIN ANALYSIS 44
4 COMPETITIVE LANDSCAPE 46
4.1 OVERVIEW 46
4.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025 46
4.3 REVENUE ANALYSIS, 2020-2024 48
4.4 MARKET SHARE ANALYSIS, 2024 49
4.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 51
4.5.1 STARS 51
4.5.2 EMERGING LEADERS 51
4.5.3 PERVASIVE PLAYERS 51
4.5.4 PARTICIPANTS 51
4.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 52
4.5.5.1 Company footprint 52
4.5.5.2 Product footprint 54
4.5.5.3 Application footprint 55
4.5.5.4 End user footprint 56
4.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 56
4.6.1 PROGRESSIVE COMPANIES 56
4.6.2 RESPONSIVE COMPANIES 57
4.6.3 DYNAMIC COMPANIES 57
4.6.4 STARTING BLOCKS 57
4.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 58
4.6.5.1 Detailed list of key startups/SMEs 58
4.6.5.2 Competitive benchmarking of key startups/SMEs 58
4.7 R&D EXPENDITURE OF KEY PLAYERS 59
4.8 COMPANY VALUATION AND FINANCIAL METRICS 59
4.8.1 COMPANY VALUATION 59
4.8.2 FINANCIAL METRICS 60
4.9 BRAND/PRODUCT COMPARISON 61
4.10 COMPETITIVE SCENARIO 62
4.10.1 PRODUCT LAUNCHES & APPROVALS 62
4.10.2 DEALS 65
4.10.3 EXPANSIONS 67
4.10.4 OTHER DEVELOPMENTS 68
5 COMPANY PROFILES 70
5.1 KEY PLAYERS 70
5.1.1 BECTON, DICKINSON AND COMPANY 70
5.1.1.1 Business overview 70
5.1.1.2 Products offered 71
5.1.1.3 Recent developments 74
5.1.1.3.1 Product launches & approvals 74
5.1.1.3.2 Deals 74
5.1.1.3.3 Expansions 75
5.1.1.3.4 Other developments 75
5.1.1.4 MnM view 76
5.1.1.4.1 Right to win 76
5.1.1.4.2 Strategic choices 76
5.1.1.4.3 Weaknesses and competitive threats 76
5.1.2 B. BRAUN MELSUNGEN AG 77
5.1.2.1 Business overview 77
5.1.2.2 Products offered 78
5.1.2.3 Recent developments 83
5.1.2.3.1 Product launches & approvals 83
5.1.2.3.2 Deals 84
5.1.2.3.3 Other developments 84
5.1.2.4 MnM view 84
5.1.2.4.1 Right to win 84
5.1.2.4.2 Strategic choices 85
5.1.2.4.3 Weaknesses and competitive threats 85
5.1.3 BAXTER INTERNATIONAL INC. 86
5.1.3.1 Business overview 86
5.1.3.2 Products offered 87
5.1.3.3 Recent developments 89
5.1.3.3.1 Product launches & approvals 89
5.1.3.3.2 Deals 89
5.1.3.3.3 Other developments 89
5.1.3.4 MnM view 90
5.1.3.4.1 Right to win 90
5.1.3.4.2 Strategic choices 90
5.1.3.4.3 Weaknesses and competitive threats 90
5.1.4 FRESENIUS KABI 91
5.1.4.1 Business overview 91
5.1.4.2 Products offered 92
5.1.4.3 Recent developments 95
5.1.4.3.1 Product launches & approvals 95
5.1.4.3.2 Deals 95
5.1.4.3.3 Other developments 96
5.1.4.4 MnM view 96
5.1.4.4.1 Right to win 96
5.1.4.4.2 Strategic choices 96
5.1.4.4.3 Weaknesses and competitive threats 96
5.1.5 MEDTRONIC PLC 97
5.1.5.1 Business overview 97
5.1.5.2 Products offered 98
5.1.5.3 Recent developments 99
5.1.5.3.1 Product launches & approvals 99
5.1.5.3.2 Deals 100
5.1.5.4 MnM view 100
5.1.5.4.1 Right to win 100
5.1.5.4.2 Strategic choices 100
5.1.5.4.3 Weaknesses and competitive threats 101
5.1.6 TERUMO CORPORATION 102
5.1.6.1 Business overview 102
5.1.6.2 Products offered 103
5.1.6.3 Recent developments 104
5.1.6.3.1 Product launches & approvals 104
5.1.6.3.2 Expansions 105
5.1.6.3.3 Deals 105
5.1.7 ICU MEDICAL, INC. 106
5.1.7.1 Business overview 106
5.1.7.2 Products offered 107
5.1.7.3 Recent developments 108
5.1.7.3.1 Product launches & approvals 108
5.1.7.3.2 Deals 109
5.1.7.3.3 Other developments 109
5.1.8 AVANOS MEDICAL, INC. 110
5.1.8.1 Business overview 110
5.1.8.2 Products offered 111
5.1.9 NIPRO CORPORATION 113
5.1.9.1 Business overview 113
5.1.9.2 Products offered 114
5.1.9.3 Recent developments 115
5.1.9.3.1 Expansions 115
5.1.10 JMS CO., LTD. 117
5.1.10.1 Business overview 117
5.1.10.2 Products offered 118
5.1.11 CARDINAL HEALTH, INC. 120
5.1.11.1 Business overview 120
5.1.11.2 Products offered 121
5.1.12 ROCHE DIAGNOSTICS 123
5.1.12.1 Business overview 123
5.1.12.2 Products offered 124
5.1.12.3 Recent developments 125
5.1.12.3.1 Expansions 125
5.1.13 ABBOTT LABORATORIES 126
5.1.13.1 Business overview 126
5.1.13.2 Products offered 127
5.1.14 DANAHER CORPORATION 128
5.1.14.1 Business overview 128
5.1.14.2 Products offered 129
5.1.15 YPSOMED HOLDING AG 131
5.1.15.1 Business overview 131
5.1.15.2 Products offered 132
5.2 OTHER PLAYERS 133
5.2.1 SOOIL DEVELOPMENTS CO., LTD. 133
5.2.2 EPIC MEDICAL 134
5.2.3 MINDRAY MEDICAL INTERNATIONAL LIMITED 135
5.2.4 BIONET CO., LTD. 136
5.2.5 TANDEM DIABETES CARE, INC. 137
5.2.6 SHENZHEN MEDRENA BIOTECH CO., LTD. 138
5.2.7 ALLIED MEDICAL LIMITED 139
5.2.8 BPL MEDICAL TECHNOLOGIES 140
5.2.9 NAREENA LIFESCIENCES PRIVATE LIMITED 141
5.2.10 HARVARD BIOSCIENCE INC. 142
6 APPENDIX 143
6.1 RESEARCH METHODOLOGY 143
6.1.1 RESEARCH APPROACH 143
6.1.1.1 Secondary data 144
6.1.1.2 Primary data 144
6.1.2 RESEARCH ASSUMPTIONS 145
6.2 COMPANY EVALUATION MATRIX: METHODOLOGY 146
6.3 AUTHOR DETAILS 149
TABLE 1 RECENT DEVELOPMENTS IN SMART PUMP-EMR INTEROPERABILITY 27
TABLE 2 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 29
TABLE 3 ASEAN INFUSION PUMPS MARKET: MAJOR PATENTS 38
TABLE 4 ASEAN INFUSION PUMPS MARKET: KEY CONFERENCES AND EVENTS, 2025-2026 39
TABLE 5 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 41
TABLE 6 ASEAN INFUSION PUMP PROVIDERS: ROLE OF COMPANIES IN ECOSYSTEM 43
TABLE 7 ASEAN INFUSION PUMPS MARKET: OVERVIEW OF STRATEGIES ADOPTED
BY KEY PLAYERS, 2022-2025 46
TABLE 8 ASEAN INFUSION PUMPS MARKET: DEGREE OF COMPETITION 49
TABLE 9 ASEAN INFUSION PUMPS MARKET: PRODUCT FOOTPRINT 54
TABLE 10 ASEAN INFUSION PUMPS MARKET: APPLICATION FOOTPRINT 55
TABLE 11 ASEAN INFUSION PUMPS MARKET: END USER FOOTPRINT 56
TABLE 12 ASEAN INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 58
TABLE 13 ASEAN INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 58
TABLE 14 ASEAN INFUSION PUMPS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022-MAY 2025 62
TABLE 15 ASEAN INFUSION PUMPS MARKET: DEALS, JANUARY 2022-MAY 2025 65
TABLE 16 ASEAN INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2022-MAY 2025 67
TABLE 17 ASEAN INFUSION PUMPS MARKET: OTHER DEVELOPMENTS,
JANUARY 2022-MARCH 2025 68
TABLE 18 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 70
TABLE 19 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 71
TABLE 20 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS 74
TABLE 21 BECTON, DICKINSON AND COMPANY: DEALS 74
TABLE 22 BECTON, DICKINSON AND COMPANY: EXPANSIONS 75
TABLE 23 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS 75
TABLE 24 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 77
TABLE 25 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 78
TABLE 26 B. BRAUN MELSUNGEN AG: PRODUCT LAUNCHES & APPROVALS 83
TABLE 27 B. BRAUN MELSUNGEN AG: DEALS 84
TABLE 28 B. BRAUN MELSUNGEN AG: OTHER DEVELOPMENTS 84
TABLE 29 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 86
TABLE 30 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED 87
TABLE 31 BAXTER INTERNATIONAL INC.: PRODUCT LAUNCHES & APPROVALS 89
TABLE 32 BAXTER INTERNATIONAL INC.: DEALS 89
TABLE 33 BAXTER INTERNATIONAL INC.: OTHER DEVELOPMENTS 89
TABLE 34 FRESENIUS KABI: COMPANY OVERVIEW 91
TABLE 35 FRESENIUS KABI: PRODUCTS OFFERED 92
TABLE 36 FRESENIUS KABI: PRODUCT LAUNCHES & APPROVALS 95
TABLE 37 FRESENIUS KABI: DEALS 95
TABLE 38 FRESENIUS KABI: OTHERS, JANUARY 2022-APRIL 202 96
TABLE 39 MEDTRONIC PLC: COMPANY OVERVIEW 97
TABLE 40 MEDTRONIC PLC: PRODUCTS OFFERED 98
TABLE 41 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS 99
TABLE 42 MEDTRONIC PLC: DEALS 100
TABLE 43 TERUMO CORPORATION: COMPANY OVERVIEW 102
TABLE 44 TERUMO CORPORATION: PRODUCTS OFFERED 103
TABLE 45 TERUMO CORPORATION: PRODUCT LAUNCHES & APPROVALS 104
TABLE 46 TERUMO CORPORATION: EXPANSIONS 105
TABLE 47 TERUMO CORPORATION: DEALS 105
TABLE 48 ICU MEDICAL, INC.: COMPANY OVERVIEW 106
TABLE 49 ICU MEDICAL, INC.: PRODUCTS OFFERED 107
TABLE 50 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS 108
TABLE 51 ICU MEDICAL, INC.: DEALS 109
TABLE 52 ICU MEDICAL, INC.: OTHER DEVELOPMENTS 109
TABLE 53 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 110
TABLE 54 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 111
TABLE 55 NIPRO CORPORATION: COMPANY OVERVIEW 113
TABLE 56 NIPRO CORPORATION: PRODUCTS OFFERED 114
TABLE 57 NIPRO CORPORATION: EXPANSIONS 115
TABLE 58 JMS CO., LTD.: COMPANY OVERVIEW 117
TABLE 59 JMS CO., LTD.: PRODUCTS OFFERED 118
TABLE 60 CARDINAL HEALTH, INC.: COMPANY OVERVIEW 120
TABLE 61 CARDINAL HEALTH, INC.: PRODUCTS OFFERED 121
TABLE 62 ROCHE DIAGNOSTICS: COMPANY OVERVIEW 123
TABLE 63 ROCHE DIAGNOSTICS: PRODUCTS OFFERED 124
TABLE 64 ROCHE DIAGNOSTICS: EXPANSIONS 125
TABLE 65 ABBOTT LABORATORIES: COMPANY OVERVIEW 126
TABLE 66 ABBOTT LABORATORIES: PRODUCTS OFFERED 127
TABLE 67 DANAHER CORPORATION: COMPANY OVERVIEW 128
TABLE 68 DANAHER CORPORATION: PRODUCTS OFFERED 129
TABLE 69 YPSOMED HOLDING AG: COMPANY OVERVIEW 131
TABLE 70 YPSOMED HOLDING AG: PRODUCTS OFFERED 132
FIGURE 1 ASEAN INFUSION PUMPS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 15
FIGURE 2 ASEAN INFUSION PUMPS MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 16
FIGURE 3 ASEAN INFUSION PUMPS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 17
FIGURE 4 ASEAN INFUSION PUMPS MARKET: GEOGRAPHIC SNAPSHOT 18
FIGURE 5 ASEAN INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 19
FIGURE 6 ASIAN CANCER INCIDENCE, 2020-2040 21
FIGURE 7 DIABETES PREVALENCE IN PEOPLE AGED 65-99 YEARS, BY REGION
(2024 VS. 2050) 21
FIGURE 8 ASEAN INFUSION PUMPS MARKET: PORTER'S FIVE FORCES ANALYSIS 35
FIGURE 9 ASEAN INFUSION PUMPS MARKET: PATENTS APPLIED AND GRANTED,
JANUARY 2014-MAY 2025 37
FIGURE 10 TOP PATENT APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMPS,
JANUARY 2014-MAY 2025 38
FIGURE 11 AI USE CASES 41
FIGURE 12 ASEAN INFUSION PUMPS MARKET: ECOSYSTEM ANALYSIS 43
FIGURE 13 ASEAN INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 44
FIGURE 14 ASEAN INFUSION PUMPS MARKET: SUPPLY CHAIN ANALYSIS 45
FIGURE 15 ASEAN INFUSION PUMPS MARKET: REVENUE ANALYSIS OF
TOP FIVE PLAYERS, 2020-2024 48
FIGURE 16 SHARE ANALYSIS OF ASEAN INFUSION PUMPS MARKET, 2024 49
FIGURE 17 ASEAN INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS, 2024 52
FIGURE 18 ASEAN INFUSION PUMPS MARKET: COMPANY FOOTPRINT 53
FIGURE 19 ASEAN INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 57
FIGURE 20 R&D EXPENDITURE OF KEY PLAYERS IN ASEAN INFUSION PUMPS MARKET, 2022?2024 59
FIGURE 21 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 59
FIGURE 22 EV/EBITDA OF KEY VENDORS 60
FIGURE 23 ASEAN INFUSION PUMPS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 61
FIGURE 24 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 71
FIGURE 25 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2024) 78
FIGURE 26 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2024) 87
FIGURE 27 FRESENIUS KABI: COMPANY SNAPSHOT (2024) 92
FIGURE 28 MEDTRONIC PLC: COMPANY SNAPSHOT (2024) 98
FIGURE 29 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 103
FIGURE 30 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 107
FIGURE 31 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2024) 111
FIGURE 32 NIPRO CORPORATION: COMPANY SNAPSHOT (2024) 114
FIGURE 33 JMS CO., LTD.: COMPANY SNAPSHOT (2024) 118
FIGURE 34 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2024) 121
FIGURE 35 ROCHE DIAGNOSTICS.: COMPANY SNAPSHOT (2024) 124
FIGURE 36 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 127
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 129
FIGURE 38 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2024) 132
FIGURE 39 RESEARCH DESIGN 143
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security